Trial intelligence / Profile preview

StatinTB Trial

PACTR202211865409139Phase 2Recruiting

Sponsor
University of Cape Town
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Tuberculosis (TB) comparing Atorvastatin arm with Placebo arm (2 arms). Primary endpoint: Persistent lung inflammation on PET/CT. Started Jul 2020; status: recruiting.

02

Drugs

atorvastatin
03

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on PACTR202211865409139.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202211865409139.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call